Generate a tailored SOP for Dr. Richard Dillon. Improve your application with a focused, well-structured draft.
Richard Dillon is a Clinical Senior Lecturer in Cancer Genetics at King's College London and a Consultant Haematologist at Guy’s Hospital. He leads a research group focused on Acute Myeloid Leukaemia (AML), utilizing advanced molecular techniques to refine outcome prediction and personalize treatment for patients diagnosed with AML. Dr. Dillon's work is supported by funding from multiple organizations, including Blood Cancer UK and Cancer Research UK. He is actively involved in multiple clinical trials aimed at investigating new treatments for AML patients, demonstrating a commitment to improving the quality of life for those affected by this challenging cancer. His team at King's College London is dedicated to pioneering innovative approaches to tailor AML treatment to individual patients.
King's College London • London, UK
Teaching and research in Cancer Genetics, focusing on Acute Myeloid Leukaemia.
Requirements are consistent across King's Business School and Social Science & Public Policy departments for standard Master's entries.